Fig. 2
From: Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
Patient characteristics and EDSS outcome. Part A demonstrates the number of previous DMTs per patient prior to siponimod treatment. Part B shows the number of patients at each point in follow-up and the corresponding mean EDSS at that time. Part C demonstrates the cohort divided into age above and below 50 and associated EDSS over time, with the number of patients at each time point of follow up given. Part D displays the EDSS over time with patient number at each follow-up point included, with the cohort divided into EDSS ≤ 4 or > 4. EDSS, Expanded Disability Status Scale